PARP1 deficiency mitigates amyloid pathology, neurodegeneration, and cognitive decline in a familial Alzheimer’s disease model PNAS (2026), (Vol. 123, 20). DOI: 10.1073/pnas.2525028123 Jhaldiyal, A., Kumari, M., Guttman, L. et al. (2026)
PNAS (2026), (Vol. 123, 20). DOI: 10.1073/pnas.2525028123
